Narrative review / 2010
A review notes that patients with erectile dysfunction have reduced circulating endothelial progenitor cells and discusses nutraceutical interventions.
A review of PubMed literature was conducted to examine the molecular and cellular processes involved in erectile dysfunction (ED), focusing on circulating endothelial progenitor cells (EPC) and nutraceutical intervention. Patients with ED appear to have a reduced number of circulating EPC, which is associated with poor endothelial function possibly due to underlying low-grade inflammation. The authors highlight that interventions aimed at increasing circulating EPC, including nutraceutical supplementation such as the product Stem-Kine, may have potential in treating vascular ED.
- Study type
- Literature review
- Who was studied
- Patients with erectile dysfunction (literature review)
- What was measured
- Circulating endothelial progenitor cells and erectile dysfunction
THE PAPER
Circulating endothelial progenitor cells and erectile dysfunction: possibility of nutritional intervention?
Ichim TE, Zhong Z, Mikirova NA, Jackson JA, Hunninghake R, Mansilla E, Marín G, Núñez L, Patel AN, Angle N, Murphy MP, Dasanu CA, Alexandrescu DT, Bogin V, Riordan NH. Panminerva Med, 2010.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.